And yet, while this strategy has indeed resulted in better outcomes, the acute and long-term morbidity of therapy has been substantial. Children with high-risk cancers who receive dose-intensive chemotherapy have a greater than 80% chance of experiencing at least one severe, life-threatening, or fatal drug-related toxic event over the course of their treatment.